T1	Drug 20 24	NOAC
T2	Temporal 25 99	within 90 days prior to hospitalization or outpatient clinic visit for VTE
T5	Condition 96 99	VTE
T3	Reference_point 49 99	hospitalization or outpatient clinic visit for VTE
T4	Procedure 49 64	hospitalization
T6	Procedure 68 91	outpatient clinic visit
T7	Visit 68 85	outpatient clinic
R1	AND Arg1:T6 Arg2:T5	
R2	multi Arg1:T6 Arg2:T7	
T8	Visit 49 64	hospitalization
R3	multi Arg1:T4 Arg2:T8	
R4	Has_index Arg1:T2 Arg2:T3	
*	OR T6 T4
T9	Scope 49 99	hospitalization or outpatient clinic visit for VTE
R5	multi Arg1:T3 Arg2:T9	
R6	Has_temporal Arg1:T1 Arg2:T2	
T10	Drug 116 120	NOAC
T11	Observation 116 131	NOAC preference
R7	multi Arg1:T11 Arg2:T10	
T12	Non-representable 132 202	apart from preference consistent with current cluster randomized NOAC.
T13	Condition 210 227	contraindications
T14	Qualifier 204 209	Other
R8	Has_qualifier Arg1:T13 Arg2:T14	
T15	Qualifier 246 280	Summary of Product Characteristics
R9	Has_qualifier Arg1:T13 Arg2:T15	
T16	Drug 301 305	NOAC
R10	AND Arg1:T13 Arg2:T16	
